JSPR – jasper therapeutics, inc. - class a (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

JSPR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/13

03:20 pm

jspr

Jasper Therapeutics initiated with a Buy at Rodman & Renshaw

Low Report

Jasper Therapeutics initiated with a Buy at Rodman & Renshaw

Report

1/13

03:20 pm

jspr

Jasper Therapeutics initiated with a Buy at Rodman & Renshaw

Low Report

Jasper Therapeutics initiated with a Buy at Rodman & Renshaw

Report

1/13

10:58 am

jspr

Jasper Therapeutics (NASDAQ:JSPR) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.

Low Report

Jasper Therapeutics (NASDAQ:JSPR) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.

Report

1/13

10:58 am

jspr

Jasper Therapeutics (NASDAQ:JSPR) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.

Low Report

Jasper Therapeutics (NASDAQ:JSPR) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.

Report

11/11

10:24 am

jspr

Rating for JSPR

Low Report

Rating for JSPR

Report

11/11

10:24 am

jspr

Rating for JSPR

Low Report

Rating for JSPR

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.